Dolovich M
Department of Medicine, St. Joseph's Hospital, McMaster University, Hamilton, Ontario, Canada.
J Aerosol Med. 1991 Fall;4(3):251-63. doi: 10.1089/jam.1991.4.251.
Measurement of the aerodynamic size of an aerosol allows a prediction of its deposition efficiency and behaviour in the lung. The dynamics of volatile or pressurized (MDI) aerosols presents problems not encountered in the characterization of solid or liquid particles alone. For example, the data obtained in real-time sampling as opposed to measuring an aged aerosol provide a truer representation of circumstances during actual clinical use, yet this may be difficult to achieve due to propellent evaporation. A number of particle sizing systems have been developed based upon light scattering techniques and aerodynamic principles. Each method has its limitations; in general, they successfully measure the aerodynamic size distributions of MDI aerosols. Cascade impactors, the "gold standard" of the industry have the advantage that they allow analysis of drug mass as well as other tracers within the aerosol, but the process as a whole is labour intensive, with limited resolution. Highly automated laser-based systems developed over the past 10 years measure the surface characteristics of the aerosol rather than the direct measurement of mass. Because of different values obtained from various sizing systems, it is suggested that all MDI drugs be sized using cascade impactors but that parallel data be obtained using an alternative sizing system.
测量气溶胶的空气动力学粒径有助于预测其在肺部的沉积效率和行为。挥发性或加压(MDI)气雾剂的动力学特性带来了仅表征固体或液体颗粒时不会遇到的问题。例如,与测量老化后的气雾剂相比,实时采样获得的数据能更真实地反映实际临床使用中的情况,但由于推进剂蒸发,这可能难以实现。基于光散射技术和空气动力学原理,已经开发出了多种颗粒粒径测量系统。每种方法都有其局限性;总体而言,它们能成功测量MDI气雾剂的空气动力学粒径分布。级联撞击器是该行业的“金标准”,其优点是可以分析气雾剂中的药物质量以及其他示踪剂,但整个过程劳动强度大,分辨率有限。过去十年中开发的高度自动化的激光系统测量的是气雾剂的表面特性,而不是直接测量质量。由于各种粒径测量系统得到的值不同,建议使用级联撞击器对所有MDI药物进行粒径测量,但同时使用另一种粒径测量系统获取平行数据。